The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michael Miller

Division of Cardiology

University of Maryland Medical Center

Baltimore

Maryland 21201

USA

[email]@*.umaryland.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cardiology, University of Maryland Medical Center, Baltimore, Maryland 21201, USA. 2000 - 2008
  • University of Maryland School of Medicine, Baltimore, MD 21201, USA. 2007
  • Division of Cardiology, Department of Medicine, Veterans Affairs Medical Center/University of Maryland, Baltimore, USA. 2003

References

  1. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. Miller, M., Cannon, C.P., Murphy, S.A., Qin, J., Ray, K.K., Braunwald, E. J. Am. Coll. Cardiol. (2008) [Pubmed]
  2. Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?. Miller, M. Prev. Cardiol (2007) [Pubmed]
  3. The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a SILHOUETTE trial sub-study. Miller, M., Dobs, A., Yuan, Z., Battisti, W.P., Palmisano, J. Curr. Med. Res. Opin (2006) [Pubmed]
  4. Bezafibrate reduces the incidence of type 2 diabetes mellitus in patients with obesity. Miller, M. Nature Clinical Practice. Endocrinology & Metabolism (2006) [Pubmed]
  5. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Miller, M., Zhan, M., Havas, S. Arch. Intern. Med. (2005) [Pubmed]
  6. Genetic determinants of low high-density lipoprotein cholesterol. Miller, M., Zhan, M. Curr. Opin. Cardiol. (2004) [Pubmed]
  7. Effect of desirable fasting triglycerides on the postprandial response to dietary fat. Miller, M., Zhan, M., Georgopoulos, A. J. Investig. Med. (2003) [Pubmed]
  8. Raising an isolated low HDL-C level: why, how, and when?. Miller, M. Cleve. Clin. J. Med (2003) [Pubmed]
  9. Genetics of HDL regulation in humans. Miller, M., Rhyne, J., Hamlette, S., Birnbaum, J., Rodriguez, A. Curr. Opin. Lipidol. (2003) [Pubmed]
  10. Niacin as a component of combination therapy for dyslipidemia. Miller, M. Mayo Clin. Proc. (2003) [Pubmed]
  11. Update on the role of triglycerides as a risk factor for coronary heart disease. Miller, M., Cosgrove, B., Havas, S. Curr. Atheroscler. Rep (2002) [Pubmed]
  12. Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians. Miller, M., Rhyne, J., Khatta, M., Parekh, H., Zeller, K. Am. J. Cardiol. (2001) [Pubmed]
  13. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia. Miller, M., Dolinar, C., Cromwell, W., Otvos, J.D. Am. J. Cardiol. (2001) [Pubmed]
  14. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Miller, M., Byington, R., Hunninghake, D., Pitt, B., Furberg, C.D. Arch. Intern. Med. (2000) [Pubmed]
  15. Current perspectives on the management of hypertriglyceridemia. Miller, M. Am. Heart J. (2000) [Pubmed]
 
WikiGenes - Universities